Andrew T Wood

Title: Innovations and Contributions of Andrew T. Wood

Introduction

Andrew T. Wood is an accomplished inventor based in Newtown, PA (US). He holds two patents that reflect his significant contributions to the field of biotechnology. His work primarily focuses on polypeptides and their applications in modulating apoptosis, particularly in neural cells.

Latest Patents

One of Andrew's latest patents is related to a polypeptide known as Pablo, which interacts with Bcl-xL. This invention includes polypeptides that contain Bcl-xL binding domains, novel Bcl-xL binding domains of Pablo polypeptides, and nucleic acid molecules encoding such polypeptides. These innovations are particularly useful in modulating apoptosis and can aid in the treatment or prevention of disorders that benefit from the modulation of cell death. Another significant patent involves the MORT1 gene, which was initially cloned from HeLa cells and identified as part of the receptor-mediated apoptotic pathway. This gene is expressed in the human neuronal cell line, NTERA2, and has revealed transcript isoforms that differ from the known MORT1 sequence.

Career Highlights

Throughout his career, Andrew has worked with notable companies such as Wyeth and American Home Products Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Andrew has collaborated with several professionals, including Kathleen H. Young and Robert Mark. These collaborations have likely enriched his research and development efforts.

Conclusion

Andrew T. Wood's contributions to biotechnology through his patents and collaborations highlight his role as an innovative inventor. His work continues to impact the understanding and treatment of apoptosis in neural cells.